Click for best price
Cryptococcosis Therapeutics Market Size, Share 2023
This report contains market size and forecasts of Cryptococcosis Therapeutics in Global, including the following market information:
Global Cryptococcosis Therapeutics Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cryptococcosis Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Amphotericin B Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cryptococcosis Therapeutics include Bristol-Myers Squibb, Abbott Laboratories, Pfizer, Glenmark Pharmaceuticals, Bausch Health, Johnson & Johnson, Novartis AG, Janssen Biotech and Sigmapharm Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cryptococcosis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cryptococcosis Therapeutics Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Cryptococcosis Therapeutics Market Segment Percentages, by Type, 2022 (%)
Amphotericin B
Flucytosine
Fluconazole
Others
Global Cryptococcosis Therapeutics Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Cryptococcosis Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Others
Global Cryptococcosis Therapeutics Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Cryptococcosis Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cryptococcosis Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cryptococcosis Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Abbott Laboratories
Pfizer
Glenmark Pharmaceuticals
Bausch Health
Johnson & Johnson
Novartis AG
Janssen Biotech
Sigmapharm Laboratories
Astellas Pharma Inc
Valeant Pharmaceuticals
| Report Attributes |
Report Details |
| Report Title |
Cryptococcosis Therapeutics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cryptococcosis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cryptococcosis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cryptococcosis Therapeutics Overall Market Size
2.1 Global Cryptococcosis Therapeutics Market Size: 2022 VS 2030
2.2 Global Cryptococcosis Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cryptococcosis Therapeutics Players in Global Market
3.2 Top Global Cryptococcosis Therapeutics Companies Ranked by Revenue
3.3 Global Cryptococcosis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Cryptococcosis Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cryptococcosis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cryptococcosis Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Cryptococcosis Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Cryptococcosis Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cryptococcosis Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Amphotericin B
4.1.3 Flucytosine
4.1.4 Fluconazole
4.1.5 Others
4.2 By Type - Global Cryptococcosis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Cryptococcosis Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Cryptococcosis Therapeutics Revenue, 2023-2030
4.2.3 By Type - Global Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cryptococcosis Therapeutics Market Size, 2022 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Cryptococcosis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Cryptococcosis Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Cryptococcosis Therapeutics Revenue, 2023-2030
5.2.3 By Application - Global Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cryptococcosis Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Cryptococcosis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Cryptococcosis Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Cryptococcosis Therapeutics Revenue, 2023-2030
6.2.3 By Region - Global Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cryptococcosis Therapeutics Revenue, 2018-2030
6.3.2 US Cryptococcosis Therapeutics Market Size, 2018-2030
6.3.3 Canada Cryptococcosis Therapeutics Market Size, 2018-2030
6.3.4 Mexico Cryptococcosis Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cryptococcosis Therapeutics Revenue, 2018-2030
6.4.2 Germany Cryptococcosis Therapeutics Market Size, 2018-2030
6.4.3 France Cryptococcosis Therapeutics Market Size, 2018-2030
6.4.4 U.K. Cryptococcosis Therapeutics Market Size, 2018-2030
6.4.5 Italy Cryptococcosis Therapeutics Market Size, 2018-2030
6.4.6 Russia Cryptococcosis Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Cryptococcosis Therapeutics Market Size, 2018-2030
6.4.8 Benelux Cryptococcosis Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cryptococcosis Therapeutics Revenue, 2018-2030
6.5.2 China Cryptococcosis Therapeutics Market Size, 2018-2030
6.5.3 Japan Cryptococcosis Therapeutics Market Size, 2018-2030
6.5.4 South Korea Cryptococcosis Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Cryptococcosis Therapeutics Market Size, 2018-2030
6.5.6 India Cryptococcosis Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cryptococcosis Therapeutics Revenue, 2018-2030
6.6.2 Brazil Cryptococcosis Therapeutics Market Size, 2018-2030
6.6.3 Argentina Cryptococcosis Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cryptococcosis Therapeutics Revenue, 2018-2030
6.7.2 Turkey Cryptococcosis Therapeutics Market Size, 2018-2030
6.7.3 Israel Cryptococcosis Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Cryptococcosis Therapeutics Market Size, 2018-2030
6.7.5 UAE Cryptococcosis Therapeutics Market Size, 2018-2030
7 Players Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Corporate Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Cryptococcosis Therapeutics Major Product Offerings
7.1.4 Bristol-Myers Squibb Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Key News
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Cryptococcosis Therapeutics Major Product Offerings
7.2.4 Abbott Laboratories Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Cryptococcosis Therapeutics Major Product Offerings
7.3.4 Pfizer Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News
7.4 Glenmark Pharmaceuticals
7.4.1 Glenmark Pharmaceuticals Corporate Summary
7.4.2 Glenmark Pharmaceuticals Business Overview
7.4.3 Glenmark Pharmaceuticals Cryptococcosis Therapeutics Major Product Offerings
7.4.4 Glenmark Pharmaceuticals Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Glenmark Pharmaceuticals Key News
7.5 Bausch Health
7.5.1 Bausch Health Corporate Summary
7.5.2 Bausch Health Business Overview
7.5.3 Bausch Health Cryptococcosis Therapeutics Major Product Offerings
7.5.4 Bausch Health Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Bausch Health Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Cryptococcosis Therapeutics Major Product Offerings
7.6.4 Johnson & Johnson Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News
7.7 Novartis AG
7.7.1 Novartis AG Corporate Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Cryptococcosis Therapeutics Major Product Offerings
7.7.4 Novartis AG Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Novartis AG Key News
7.8 Janssen Biotech
7.8.1 Janssen Biotech Corporate Summary
7.8.2 Janssen Biotech Business Overview
7.8.3 Janssen Biotech Cryptococcosis Therapeutics Major Product Offerings
7.8.4 Janssen Biotech Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Janssen Biotech Key News
7.9 Sigmapharm Laboratories
7.9.1 Sigmapharm Laboratories Corporate Summary
7.9.2 Sigmapharm Laboratories Business Overview
7.9.3 Sigmapharm Laboratories Cryptococcosis Therapeutics Major Product Offerings
7.9.4 Sigmapharm Laboratories Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Sigmapharm Laboratories Key News
7.10 Astellas Pharma Inc
7.10.1 Astellas Pharma Inc Corporate Summary
7.10.2 Astellas Pharma Inc Business Overview
7.10.3 Astellas Pharma Inc Cryptococcosis Therapeutics Major Product Offerings
7.10.4 Astellas Pharma Inc Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Astellas Pharma Inc Key News
7.11 Valeant Pharmaceuticals
7.11.1 Valeant Pharmaceuticals Corporate Summary
7.11.2 Valeant Pharmaceuticals Business Overview
7.11.3 Valeant Pharmaceuticals Cryptococcosis Therapeutics Major Product Offerings
7.11.4 Valeant Pharmaceuticals Cryptococcosis Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Valeant Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cryptococcosis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Cryptococcosis Therapeutics Market Drivers in Global Market
Table 3. Cryptococcosis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Cryptococcosis Therapeutics in Global Market
Table 5. Top Cryptococcosis Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cryptococcosis Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cryptococcosis Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cryptococcosis Therapeutics Product Type
Table 9. List of Global Tier 1 Cryptococcosis Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cryptococcosis Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cryptococcosis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cryptococcosis Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cryptococcosis Therapeutics Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Cryptococcosis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cryptococcosis Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cryptococcosis Therapeutics Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Cryptococcosis Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cryptococcosis Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cryptococcosis Therapeutics Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cryptococcosis Therapeutics Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cryptococcosis Therapeutics Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cryptococcosis Therapeutics Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cryptococcosis Therapeutics Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cryptococcosis Therapeutics Revenue, (US$, Mn), 2023-2030
Table 30. Bristol-Myers Squibb Corporate Summary
Table 31. Bristol-Myers Squibb Cryptococcosis Therapeutics Product Offerings
Table 32. Bristol-Myers Squibb Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Cryptococcosis Therapeutics Product Offerings
Table 35. Abbott Laboratories Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Cryptococcosis Therapeutics Product Offerings
Table 38. Pfizer Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
Table 39. Glenmark Pharmaceuticals Corporate Summary
Table 40. Glenmark Pharmaceuticals Cryptococcosis Therapeutics Product Offerings
Table 41. Glenmark Pharmaceuticals Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
Table 42. Bausch Health Corporate Summary
Table 43. Bausch Health Cryptococcosis Therapeutics Product Offerings
Table 44. Bausch Health Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Cryptococcosis Therapeutics Product Offerings
Table 47. Johnson & Johnson Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
Table 48. Novartis AG Corporate Summary
Table 49. Novartis AG Cryptococcosis Therapeutics Product Offerings
Table 50. Novartis AG Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
Table 51. Janssen Biotech Corporate Summary
Table 52. Janssen Biotech Cryptococcosis Therapeutics Product Offerings
Table 53. Janssen Biotech Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
Table 54. Sigmapharm Laboratories Corporate Summary
Table 55. Sigmapharm Laboratories Cryptococcosis Therapeutics Product Offerings
Table 56. Sigmapharm Laboratories Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
Table 57. Astellas Pharma Inc Corporate Summary
Table 58. Astellas Pharma Inc Cryptococcosis Therapeutics Product Offerings
Table 59. Astellas Pharma Inc Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
Table 60. Valeant Pharmaceuticals Corporate Summary
Table 61. Valeant Pharmaceuticals Cryptococcosis Therapeutics Product Offerings
Table 62. Valeant Pharmaceuticals Cryptococcosis Therapeutics Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Cryptococcosis Therapeutics Segment by Type in 2022
Figure 2. Cryptococcosis Therapeutics Segment by Application in 2022
Figure 3. Global Cryptococcosis Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cryptococcosis Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cryptococcosis Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cryptococcosis Therapeutics Revenue in 2022
Figure 8. By Type - Global Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Region - Global Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
Figure 11. By Country - North America Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
Figure 12. US Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
Figure 16. Germany Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. France Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
Figure 24. China Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 28. India Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
Figure 30. Brazil Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Cryptococcosis Therapeutics Revenue Market Share, 2018-2030
Figure 33. Turkey Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Cryptococcosis Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 37. Bristol-Myers Squibb Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Abbott Laboratories Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Pfizer Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Glenmark Pharmaceuticals Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Bausch Health Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis AG Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Janssen Biotech Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sigmapharm Laboratories Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Astellas Pharma Inc Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Valeant Pharmaceuticals Cryptococcosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
